Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Pacemakers Could Help Avoid Future Strokes
Clinical Breakthroughs

Pacemakers Could Help Avoid Future Strokes

By Will DossNov 7, 2019
Share
Facebook Twitter Email
Rod Passman, MD, MSCE, the Jules J. Reingold Professor of Electrophysiology, a professor of Medicine in the Division of Cardiology, of Preventive Medicine and senior author of the study.

Measuring atrial fibrillation (AF) through implanted devices like pacemakers can identify patients at risk for stroke, according to a Northwestern Medicine study published in Circulation.

This information could help clinicians make better treatment decisions, according to Rod Passman, MD, MSCE, the Jules J. Reingold Professor of Electrophysiology and senior author of the study.

“Not all patients are alike, even those with an identical number of stroke risk factors,” said Passman, who is also a professor of Medicine in the Division of Cardiology and of Preventive Medicine. “The amount of AF is an important contributor.”

AF is an erratic or quivering heartbeat that results in abnormal blood flow in the heart, and is the most common heart rhythm disorder in adults and a major contributor to dementia, heart failure and stroke.

Risk of stroke in patients with AF is often measured using the CHA2DS2-VASc score: a clinical score that takes into account risk factors including age and cardiovascular history, but this measure does not take into account the varying amounts of AF, which reduces the information available to clinicians and limits the treatment options, according to Passman.

“AF patients with additional stroke risk factors such as diabetes, hypertension, advanced age or heart failure are all treated the same when it comes to stroke prevention — they all are prescribed chronic anticoagulation regardless of how much AF is present,” Passman said.

Cardiovascular implantable electronic devices (CIED) can detect AF with high sensitivity and specificity, but there are no clear clinical guidelines on whether or not to initiate anti-stroke treatment in patients with device-detected AF; this information is not used as part of medical decision-making. To answer the question of how device-detected AF contributes to stroke risk, the investigators linked two databases – one including the electronic health records of over 11 million patients and the other that contained data on over 300,000 patients with CIED’s capability of monitoring AF. Out of a pool of more than 21,000 individuals from these two databases, Passman and his colleagues found that increased duration of AF was associated with a higher risk of stroke even in those individuals with similar stroke risk factors.

According to the authors, considering device-detected AF alongside the CHA2DS2-VASc score can help doctors make more informed decisions regarding initiating anti-coagulation treatment: patients with intermediate clinical risk may be pushed over the edge into anti-coagulation territory if they experience long durations of erratic heartbeat.

“Clinicians are constantly faced with questions surrounding the finding of AF in patients with implanted devices such as pacemakers, defibrillators and insertable cardiac monitors,” Passman said. “I think that this data is robust and can be used to aid clinical decision making surrounding the need for anticoagulation in patients with device detected AF.”

Rachel Kaplan, ’14 MD, ’16 GME, a third-year resident in Cardiology, was the first author of the study.

Passman receives research support and consulting fees from Medtronic.

Cardiology Patient Care Research
Share. Facebook Twitter Email

Related Posts

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Comments are closed.

Latest News

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.